| p53 represses c-Myc through induction of the tumor suppressor miR-145 M Sachdeva, S Zhu, F Wu, H Wu, V Walia, S Kumar, R Elble, K Watabe, ... Proceedings of the National Academy of Sciences 106 (9), 3207-3212, 2009 | 1017 | 2009 |
| Exome sequencing identifies GRIN2A as frequently mutated in melanoma X Wei, V Walia, JC Lin, JK Teer, TD Prickett, J Gartner, S Davis, ... Nature genetics 43 (5), 442-446, 2011 | 586 | 2011 |
| Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation Q Lu, C Insinna, C Ott, J Stauffer, PA Pintado, J Rahajeng, U Baxa, ... Nature cell biology 17 (3), 228-240, 2015 | 323 | 2015 |
| Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma TD Prickett, X Wei, I Cardenas-Navia, JK Teer, JC Lin, V Walia, J Gartner, ... Nature genetics 43 (11), 1119-1126, 2011 | 163 | 2011 |
| Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis V Walia, Y Yu, D Cao, M Sun, JR McLean, BG Hollier, J Cheng, SA Mani, ... Oncogene 31 (17), 2237-2246, 2012 | 94 | 2012 |
| hCLCA2 is a p53-inducible inhibitor of breast cancer cell proliferation V Walia, M Ding, S Kumar, D Nie, LS Premkumar, RC Elble Cancer research 69 (16), 6624-6632, 2009 | 87 | 2009 |
| Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells Y Yu, V Walia, RC Elble PloS one 8 (12), e83943, 2013 | 77 | 2013 |
| CLCA2 interactor EVA1 is required for mammary epithelial cell differentiation G Ramena, Y Yin, Y Yu, V Walia, RC Elble PLoS One 11 (3), e0147489, 2016 | 59 | 2016 |
| The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment RC Elble, V Walia, H Cheng, CJ Connon, L Mundhenk, AD Gruber, ... Journal of Biological Chemistry 281 (40), 29448-29454, 2006 | 56 | 2006 |
| Akt regulates a Rab11-effector switch required for ciliogenesis V Walia, A Cuenca, M Vetter, C Insinna, S Perera, Q Lu, DA Ritt, E Semler, ... Developmental cell 50 (2), 229-246. e7, 2019 | 53 | 2019 |
| Delving into somatic variation in sporadic melanoma V Walia, EW Mu, JC Lin, Y Samuels Pigment cell & melanoma research 25 (2), 155-170, 2012 | 47 | 2012 |
| p53 in breast cancer: mutation and countermeasures S Kumar, V Walia, M Ray, RC Elble Front Biosci 12 (1), 4, 2007 | 45 | 2007 |
| Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion V Walia, RC Elble Stem cells and development 19 (8), 1175-1182, 2010 | 44 | 2010 |
| Mutational and functional analysis of the tumor‐suppressor PTPRD in human melanoma V Walia, TD Prickett, JS Kim, JJ Gartner, JC Lin, M Zhou, SA Rosenberg, ... Human mutation 35 (11), 1301-1310, 2014 | 33 | 2014 |
| Micromanagement of the mitochondrial apoptotic pathway by p53 V Walia, S Kakar, R Elble Front Biosci 16 (1), 749-758, 2011 | 29 | 2011 |
| The C7orf43/TRAPPC14 component links the TRAPPII complex to Rabin8 for preciliary vesicle tethering at the mother centriole during ciliogenesis A Cuenca, C Insinna, H Zhao, P John, MA Weiss, Q Lu, V Walia, S Specht, ... Journal of Biological Chemistry 294 (42), 15418-15434, 2019 | 22 | 2019 |
| Oncogenic RAS-induced perinuclear signaling complexes requiring KSR1 regulate signal transmission to downstream targets SK Basu, S Lee, J Salotti, S Basu, K Sakchaisri, Z Xiao, V Walia, ... Cancer research 78 (4), 891-908, 2018 | 19 | 2018 |
| Program NCS, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Samuels Y: Exome sequencing identifies GRIN2A as frequently mutated in melanoma X Wei, V Walia, JC Lin, JK Teer, TD Prickett, J Gartner, S Davis Nat Genet 43 (5), 442-6, 2011 | 15 | 2011 |
| Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq KL Harris, V Walia, B Gong, KL McKim, MB Myers, J Xu, BL Parsons Environmental and Molecular Mutagenesis 61 (9), 872-889, 2020 | 7 | 2020 |
| Analysis of enzymatic activity of matrix metalloproteinase (MMP) by collagen zymography in Melanoma V Walia, Y Samuels Proteases and Cancer: Methods and Protocols, 97-106, 2018 | 4 | 2018 |
